More about Masitinib

[KoKo]

I really like the phrase "significantly slows disability progression".

Masitinib Slows Disability Progression in PPMS, Non-active SPMS

"Masitinib, AB Science’s experimental oral therapy, significantly slows disability progression in adults with primary progressive multiple sclerosis (PPMS) and non-active secondary progressive MS (SPMS), according to final data from the AB07002 Phase 2b/3 clinical trial."

Masitinib Slows Disability Progression in PPMS, Non-active SPMS (multiplesclerosisnewstoday.com)

[Seasha]

Thanks for this KoKo! It is something to keep an eye on for the future. Something I'd be willing to try!

[KoKo]

Thanks for this KoKo! It is something to keep an eye on for the future. Something I'd be willing to try!

Me too!

Also, it's an oral drug and it's not an immunosuppressive drug.